| Chemically induced mouse models of intestinal inflammation S Wirtz, C Neufert, B Weigmann, MF Neurath Nature protocols 2 (3), 541-546, 2007 | 1794 | 2007 |
| Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis … R Atreya, J Mudter, S Finotto, J Müllberg, T Jostock, S Wirtz, M Schütz, ... Nature medicine 6 (5), 583-588, 2000 | 1562 | 2000 |
| STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing G Pickert, C Neufert, M Leppkes, Y Zheng, N Wittkopf, M Warntjen, ... Journal of Experimental Medicine 206 (7), 1465-1472, 2009 | 1133 | 2009 |
| IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases P Shen, T Roch, V Lampropoulou, RA O’Connor, U Stervbo, E Hilgenberg, ... Nature 507 (7492), 366-370, 2014 | 1120 | 2014 |
| Chemically induced mouse models of acute and chronic intestinal inflammation S Wirtz, V Popp, M Kindermann, K Gerlach, B Weigmann, S Fichtner-Feigl, ... Nature protocols 12 (7), 1295-1309, 2017 | 1037 | 2017 |
| CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes I Tiede, G Fritz, S Strand, D Poppe, R Dvorsky, D Strand, HA Lehr, S Wirtz, ... The Journal of clinical investigation 111 (8), 1133-1145, 2003 | 1019 | 2003 |
| TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling C Becker, MC Fantini, C Schramm, HA Lehr, S Wirtz, A Nikolaev, J Burg, ... Immunity 21 (4), 491-501, 2004 | 928 | 2004 |
| Mouse models of inflammatory bowel disease S Wirtz, MF Neurath Advanced drug delivery reviews 59 (11), 1073-1083, 2007 | 662 | 2007 |
| RORγ-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F M Leppkes, C Becker, II Ivanov, S Hirth, S Wirtz, C Neufert, S Pouly, ... Gastroenterology 136 (1), 257-267, 2009 | 540 | 2009 |
| Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis T Mchedlidze, M Waldner, S Zopf, J Walker, AL Rankin, M Schuchmann, ... Immunity 39 (2), 357-371, 2013 | 538 | 2013 |
| Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells C Becker, S Wirtz, M Blessing, J Pirhonen, D Strand, O Bechthold, J Frick, ... The Journal of clinical investigation 112 (5), 693-706, 2003 | 469 | 2003 |
| TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells K Gerlach, YY Hwang, A Nikolaev, R Atreya, H Dornhoff, S Steiner, ... Nature immunology 15 (7), 676-686, 2014 | 422 | 2014 |
| IL-6 signaling promotes tumor growth in colorectal cancer C Becker, MC Fantini, S Wirtz, A Nikolaev, HA Lehr, PR Galle, R John, ... Cell Cycle 4 (2), 220-223, 2005 | 329 | 2005 |
| Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis N Tajik, M Frech, O Schulz, F Schälter, S Lucas, V Azizov, K Dürholz, ... Nature communications 11 (1), 1995, 2020 | 321 | 2020 |
| Autophagy regulates TNFα-mediated joint destruction in experimental arthritis NY Lin, C Beyer, A Gießl, T Kireva, C Scholtysek, S Uderhardt, LE Munoz, ... Annals of the rheumatic diseases 72 (5), 761-768, 2013 | 320 | 2013 |
| In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy C Becker, MC Fantini, S Wirtz, A Nikolaev, R Kiesslich, HA Lehr, PR Galle, ... Gut 54 (7), 950-954, 2005 | 305 | 2005 |
| Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis C Becker, H Dornhoff, C Neufert, MC Fantini, S Wirtz, S Huebner, ... The Journal of Immunology 177 (5), 2760-2764, 2006 | 285 | 2006 |
| Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells S Rauber, M Luber, S Weber, L Maul, A Soare, T Wohlfahrt, NY Lin, ... Nature medicine 23 (8), 938-944, 2017 | 272 | 2017 |
| IL‐27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1 C Neufert, C Becker, S Wirtz, MC Fantini, B Weigmann, PR Galle, ... European journal of immunology 37 (7), 1809-1816, 2007 | 266 | 2007 |
| Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus S Kiechl, J Wittmann, A Giaccari, M Knoflach, P Willeit, A Bozec, ... Nature medicine 19 (3), 358-363, 2013 | 249 | 2013 |
